Prohost Letter #402
Antisense Proof of Concept and Feasibility
EYE ON INVIVA (INVA)
Sales of The Ellipta Inhalers Started to Pick up
AND ON THERAVANCE BIOPHARMA (TBPH)
See Below
AND WE WILL NOT LOSE FOCUS ON
ARIAD (ARIA), EXELIXIS (EXEL), ARRAY (ARRY), PORTOLA (PTLA), NEKTAR (NKTR), THERAVANCE BIOPHARMA (TBPH), INVIVA (INVA), MERCK (MRK) AND
SEE THE TABLES
IONIS (IONS)
The . . .
This content is for paid subscribers.
Prohost Letters
November 30, 2016